Valuation: Sartorius AG

Market Cap 15.51B 18.11B 14.47B 13.28B 24.95B 1,733B 25.44B 172B 66.92B 869B 68.02B 66.54B 2,876B P/E 2026 *
65.3x
P/E 2027 * 50.6x
Enterprise Value 19.08B 22.29B 17.81B 16.34B 30.7B 2,133B 31.31B 211B 82.34B 1,069B 83.69B 81.87B 3,539B EV / Sales 2026 *
5.13x
EV / Sales 2027 * 4.6x
Free-Float
35.87%
Yield 2026 *
0.32%
Yield 2027 * 0.39%
1 day+6.34%
1 week+6.43%
Current month+9.50%
1 month+5.08%
3 months+10.71%
6 months+4.78%
Current year+4.38%
1 week 229.7
Extreme 229.7
248.8
1 month 212.5
Extreme 212.5
248.8
Current year 203.8
Extreme 203.8
264.6
1 year 189.45
Extreme 189.45
264.6
3 years 176.85
Extreme 176.85
381.4
5 years 176.85
Extreme 176.85
612.2
10 years 172.3
Extreme 172.3
612.2
Manager TitleAgeSince
Chief Executive Officer 59 2025-06-29
Director of Finance/CFO 55 2024-03-31
Chief Operating Officer 70 2000-12-31
Director TitleAgeSince
Director/Board Member 62 2002-08-31
Chairman 69 2017-07-18
Director/Board Member 77 2011-11-28
Change 5-day change 1-year change 3-year change Capi.($)
+6.34%+6.43% - - 17.02B
+6.05%+5.87%+25.71%-29.73% 17.02B
+4.68%-7.33%-39.72%+98.25% 1.61B
+0.52%-1.25%-22.93%+26.06% 978M
+7.61%-1.59%-43.62%-80.01% 946M
+0.16%-0.05%+64.65%-7.23% 778M
+5.55%+1.81%-35.43%-46.60% 667M
-2.07%-7.48%-42.69%-43.27% 589M
-1.79%+5.01%-42.85%-36.73% 450M
+1.07%+2.37%+73.08%+47.65% 423M
Average +2.81%-0.82%-7.09%-7.96% 2.61B
Weighted average by Cap. +5.64%+3.55%+13.77%-19.46%

Financials

2026 *2027 *
Net sales 3.72B 4.35B 3.47B 3.19B 5.99B 416B 6.11B 41.21B 16.07B 209B 16.33B 15.97B 690B 4.08B 4.77B 3.81B 3.5B 6.57B 456B 6.7B 45.21B 17.62B 229B 17.91B 17.52B 757B
Net income 256M 299M 238M 219M 411M 28.56B 419M 2.83B 1.1B 14.31B 1.12B 1.1B 47.39B 328M 383M 306M 281M 528M 36.69B 539M 3.63B 1.42B 18.39B 1.44B 1.41B 60.88B
Net Debt 3.57B 4.17B 3.33B 3.06B 5.75B 399B 5.86B 39.56B 15.42B 200B 15.67B 15.33B 663B 3.27B 3.82B 3.05B 2.8B 5.26B 365B 5.36B 36.18B 14.1B 183B 14.33B 14.02B 606B
Logo Sartorius AG
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Employees
14,279
Date Price Change Volume
26-08-20 €250.10 +6.34% 224
26-08-19 €235.20 +2.39% 74
26-08-18 €229.70 -2.42% 0
26-08-17 €235.40 -0.30% 0
26-08-14 €236.10 +0.47% 0
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
248.90EUR
Average target price
269.11EUR
Spread / Average Target
+8.12%

Quarterly revenue - Rate of surprise